Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States

Affiliations

Editorial

Timothy N Clinton et al. Transl Androl Urol. 2019 Dec.

. 2019 Dec;8(Suppl 5):S542-S545.

doi: 10.21037/tau.2019.12.22.

¹ Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
Westergren DO, Gårdmark T, Lindhagen L, Chau A, Malmström PU. Westergren DO, et al. J Urol. 2019 Nov;202(5):905-912. doi: 10.1097/JU.0000000000000350. Epub 2019 Oct 9. J Urol. 2019. PMID: 31144594

Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.
Benidir T, Herrera-Caceres J, Wallis C, Lajkosz K, Fleshner N. Benidir T, et al. Cancer Med. 2021 Apr;10(8):2636-2644. doi: 10.1002/cam4.3805. Epub 2021 Mar 12. Cancer Med. 2021. PMID: 33710797 Free PMC article.
Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation.
Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Stewart TF, Rose BS. Kotha NV, et al. Adv Radiat Oncol. 2021 Oct 25;7(1):100836. doi: 10.1016/j.adro.2021.100836. eCollection 2022 Jan-Feb. Adv Radiat Oncol. 2021. PMID: 35071834 Free PMC article.

1. Flaig T, Spiess P, Agarwal N, et al. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer Version 4.2019. In: National Comprehensive Cancer Network. Available online: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed November 26, 2019.
1. Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol 2016;196:1021-9. 10.1016/j.juro.2016.06.049 - DOI - PubMed
1. Westergren D, Gardmark T, Lindhagen L, et al. A nationwide population based analysis of patients with organ confined, muscle invasive bladder cancer not receiving curative intent therapy in Sweden from 1997-2014. J Urol 2019;202:905-12. 10.1097/JU.0000000000000350 - DOI - PubMed
1. Martini A, Sfakianos J, Renstrom-Koskela L, et al. The natural history of untreated muscle-invasive bladder cancer. BJU Int 2019. [Epub ahead of print]. 10.1111/bju.14872 - DOI - PubMed
1. Gray PJ, Fedewa SA, Shipley WU, et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol 2013;63:823-9. 10.1016/j.eururo.2012.11.015 - DOI - PubMed